Son Kyung-Bok
College of Pharmacy, Hanyang University, Ansan, Republic of Korea.
Front Med (Lausanne). 2025 Apr 30;12:1570817. doi: 10.3389/fmed.2025.1570817. eCollection 2025.
The reputation of public agencies, encompassing the dimensions of performance, morality, procedure, and technical competence, is fundamental to understanding their behavior. However, standardized, individual-level measures of reputation suitable for surveys targeting the general public are lacking. This study aims to develop and validate a survey instrument for the general public to measure the multi-dimensional reputation of public agencies, with a focus on South Korea's medicines regulatory agency.
Survey items were developed based on previous literature, refined through expert consultation, and validated through a population survey. The validation study involved 1,000 participants from the public, selected using a quota sampling method stratified by age, sex, and region, according to the South Korean census. Validity was assessed through exploratory factor analysis and hypothesis testing, while reliability was evaluated using internal consistency.
Exploratory factor analysis identified a three-dimensional structure of reputation, encompassing performance, procedure, and technical competence, while morality was not distinctly identified as a separate dimension. Construct validity, including convergent and discriminant validity, was confirmed. The internal consistency of the three dimensions was acceptable, with Cronbach's alpha coefficients ranging from 0.87 to 0.91. The overall reputation of the medicines regulatory agency was measured at 72 out of 100. The specific dimension scores were as follows: 74 for technical competence, 71 for performance, and 70 for procedure.
The agency should recognize the multidimensional nature of reputation and foster an environment that enables the public to observe and evaluate these dimensions. Reputation management strategies should emphasize not only technical expertise but also performance and procedural aspects to ensure a well-rounded reputation.
公共机构的声誉,包括绩效、道德、程序和技术能力等方面,对于理解其行为至关重要。然而,目前缺乏适用于针对普通公众的调查的标准化、个体层面的声誉衡量指标。本研究旨在开发并验证一种面向普通公众的调查工具,以衡量公共机构的多维度声誉,重点关注韩国药品监管机构。
调查项目基于以往文献制定,经专家咨询完善,并通过人口调查进行验证。验证研究涉及1000名公众参与者,采用配额抽样方法,根据韩国人口普查按年龄、性别和地区分层选取。通过探索性因素分析和假设检验评估效度,使用内部一致性评估信度。
探索性因素分析确定了声誉的三维结构,包括绩效、程序和技术能力,而道德并未被明确识别为一个单独维度。包括收敛效度和区分效度在内的结构效度得到确认。三个维度的内部一致性可接受,克朗巴哈系数在0.87至0.91之间。药品监管机构的总体声誉在100分中得分为72分。具体维度得分如下:技术能力74分,绩效71分,程序70分。
该机构应认识到声誉的多维度性质,并营造一个使公众能够观察和评估这些维度的环境。声誉管理策略不仅应强调技术专长,还应注重绩效和程序方面,以确保全面的声誉。